3 Stocks Underperforming Today In The Consumer Goods Sector

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 29 points (-0.2%) at 16,367 as of Wednesday, March 5, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,229 issues advancing vs. 1,681 declining with 174 unchanged.

The Consumer Goods sector currently is unchanged today versus the S&P 500, which is unchanged. A company within the sector that fell today was Canon ( CAJ), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3. Mead Johnson Nutrition Company ( MJN) is one of the companies pushing the Consumer Goods sector lower today. As of noon trading, Mead Johnson Nutrition Company is down $1.73 (-2.1%) to $82.33 on average volume. Thus far, 868,239 shares of Mead Johnson Nutrition Company exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $82.25-$83.98 after having opened the day at $83.78 as compared to the previous trading day's close of $84.06.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. Mead Johnson Nutrition Company has a market cap of $16.6 billion and is part of the food & beverage industry. Shares are up 0.4% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts that rate Mead Johnson Nutrition Company a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Mead Johnson Nutrition Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Mead Johnson Nutrition Company Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Kimberly-Clark Corporation ( KMB) is down $1.29 (-1.2%) to $108.73 on average volume. Thus far, 760,177 shares of Kimberly-Clark Corporation exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $108.32-$109.70 after having opened the day at $108.63 as compared to the previous trading day's close of $110.02.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and health care products worldwide. It operates through four segments: Personal Care, Consumer Tissue, K-C Professional, and Health Care. Kimberly-Clark Corporation has a market cap of $41.4 billion and is part of the consumer non-durables industry. Shares are up 4.4% year-to-date as of the close of trading on Tuesday. Currently there are 2 analysts that rate Kimberly-Clark Corporation a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Kimberly-Clark Corporation as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Kimberly-Clark Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Lorillard ( LO) is down $0.93 (-1.7%) to $54.33 on average volume. Thus far, 2.6 million shares of Lorillard exchanged hands as compared to its average daily volume of 3.8 million shares. The stock has ranged in price between $53.71-$54.66 after having opened the day at $54.19 as compared to the previous trading day's close of $55.26.

Lorillard, Inc., through its subsidiaries, manufactures and sells cigarettes in the United States. The company operates through two segments, Cigarettes and Electronic Cigarettes. Lorillard has a market cap of $19.4 billion and is part of the tobacco industry. Shares are up 5.8% year-to-date as of the close of trading on Tuesday. Currently there are 2 analysts that rate Lorillard a buy, 1 analyst rates it a sell, and 6 rate it a hold.

TheStreet Ratings rates Lorillard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Lorillard Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the consumer goods sector could consider iShares Dow Jones US Cons Goods ( IYK) while those bearish on the consumer goods sector could consider ProShares Ultra Sht Consumer Goods ( SZK).

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists